Primary cardiac disease in systemic lupus erythematosus patients: Protective and risk factors-data from a multi-ethnic Latin American cohort

Rheumatology (United Kingdom)

Volumn 53, Issue 8, 2014, Pages 1431-1438

  García, Mercedes A ^a   Alarcón, Graciela S ^b   Boggio, Gabriela ^c   Hachue, Leticia ^c   Marcos, Ana Inés ^a   Marcos, Juan Carlos ^a   Gentilett, Silvana ^d   Caeiro, Francisco ^e   Sato, Emilia I ^f   Borba, Eduardo F ^g   Tavares Brenol, João C ^h   Massardo, Loreto ⁱ   Molina Restrepo, José Fernando ^j   Vásquez, Gloria ^k   Guibert Toledano, Marlene ^l   Barile Fabris, Leonor ^m   Amigo, Mary Carmen ⁿ   Huerta Yáñe, Guillermo F ^o   Cucho Venegas, Jorge M ^p   Chacón Diaz, Rosa ^q   Pons Estel, Bernardo A ^d   more..

^a Hospital Interzonal General de Agudos de La Plata   (Argentina)

^b University of Alabama at Birmingham   (United States)

^c UNIVERSIDAD NACIONAL DE ROSARIO   (Argentina)

^d Hospital Provincial de Rosario   (Argentina)

^e HOSPITAL PRIVADO   (Argentina)

^f FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^g UNIVERSITY OF SÃO PAULO   (Brazil)

^h HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

ⁱ PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^j UNIVERSIDAD CES   (Colombia)

^k UNIVERSIDAD DE ANTIOQUIA   (Colombia)

^l Centro de Investigaciones Medico Quirurgicas   (Cuba)

^m INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

ⁿ Reumatología Centro Médico ABC   (Mexico)

^o Hospital Miguel Hidalgo   (Mexico)

^p HOSPITAL NACIONAL GUILLERMO ALMENARA IRIGOYEN   (Peru)

^q HOSPITAL UNIVERSITARIO DE CARACAS   (Venezuela)

more..

Author keywords

Antimalarials; Cardiac disease; Mortality; Survival; Systemic lupus erythematosus

Indexed keywords

ANTIMALARIAL AGENT;

ADULT; AFRICAN AMERICAN; AMERICAN INDIAN; ARTICLE; ASIAN; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CAUCASIAN; COHORT ANALYSIS; DISEASE DURATION; EDUCATIONAL STATUS; ENDOCARDITIS; ETHNIC GROUP; ETHNICITY; FEMALE; FOLLOW UP; HEALTH INSURANCE; HEART ARRHYTHMIA; HEART DISEASE; HEART PROTECTION; HUMAN; LATIN AMERICAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY (TOPIC); MYOCARDITIS; PERICARDITIS; PRIORITY JOURNAL; SLEDAI; SYSTEMIC LUPUS ERYTHEMATOSUS; VALVULAR HEART DISEASE;

ANTIMALARIALS; CARDIAC DISEASE; MORTALITY; SURVIVAL; SYSTEMIC LUPUS ERYTHEMATOSUS;

AGE OF ONSET; AGED; CAUSE OF DEATH; COMORBIDITY; FEMALE; HEART DISEASES; HUMANS; INCIDENCE; LATIN AMERICA; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 84904887450     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/keu011     Document Type: Article

References (44)

1. Doria A, Iaccarino L, Sarzi-Puttini P et al. Cardiac involvement in systemic lupus erythematosus. Lupus 2005;14:683-6.
2. Brigden W, Bywaters EG, Lessof MH, Ross IP. The heart in systemic lupus erythematosus. Br Heart J 1960;22:1-16.
3. Cervera R, Font J, Pare C et al. Cardiac disease in systemic lupus erythematosus. Ann Rheum Dis 1992;51:156-9.
4. Tincani A, Biasini-Rebaioli C, Cattaneo R, Riboldi P. Nonorgan specific autoantibodies and heart damage. Lupus 2005;14:656-9.
5. Doria A, Iaccarino L, Sarzi-Puttini P et al. Cardiac involvement in systemic lupus erythematosus. Lupus 2005;14:683-6.
6. Abdel-Aty H, Siegle N, Natusch A et al. Myocardial tissue characterization in systemic lupus erythematosus: value of a comprehensive cardiovascular magnetic resonance approach. Lupus 2008;17:561-7.
7. Pons-Estel BA, Catoggio LJ, Cardiel MH et al. The GLADEL multinational Latin American prospective inception cohort of 1,214 patients with systemic lupus erythematosus: ethnic and disease heterogeneity among ''Hispanics.'' Medicine 2004;83:1-17.
8. Tan EM, Cohen AS, Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
9. Bombardier C, Gladman DD, Urowitz MB et al. Derivation of the SLEDAI. A disease activity index for lupus patients. Arthritis Rheum 1992;35:630-40.
10. Gladman D, Ginzler E, Goldsmith C et al. The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index for systemic lupus erythematosus. Arthritis Rheum 1996;39:363-9.
11. Gladman DD, Urowitz MB, Goldsmith CH et al. The reliability of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index in patients with systemic lupus erythematosus. Arthritis Rheum 1997;40:809-13.
12. Schemper M, Smith TLA. A note on quantifying follow-up in studies of failure time. Control Clin Trials 1996;17:343-6.
13. Willis R, Seif AM, McGwin G Jr et al. Effect of hydroxychloroquine treatment on pro-inflammatory cytokines and disease activity in SLE patients: data from LUMINA (LXXV), a multiethnic US cohort. Lupus 2012;21:830-5.
14. Pons-Estel G, Alarcon G, Gonzalez L et al. Possible protective effect of hydroxychloroquine on delaying the occurrence of integument damage in lupus: LXXI, data from a multiethnic cohort. Arthritis Care Res 2010;62:393-400.
15. Alarcon GS, McGwin G, Bertoli AM et al. Effect of hydroxychloroquine on the survival of patients with systemic lupus erythematosus: data from LUMINA, a multiethnic US cohort (LUMINA L). Ann Rheum Dis 2007;66:1168-72.
16. Pons-Estel GJ, González LA, Zhang J et al. Predictors of cardiovascular damage in patients with systemic lupus erythematosus: data from LUMINA (LXVIII), a multiethnic US cohort. Rheumatology 2009;48:817-22.
17. Akhavan PS, Su J, Lou W et al. The early protective effect of hydroxychloroquine on the risk of cumulative damage in patients with systemic lupus erythematosus. J Rheumatol 2013;40:831-41.
18. Pons-Estel GJ, Alarcon GS, Hachuel L et al. Anti-malarials exert a protective effect while Mestizo patients are at increased risk of developing SLE renal disease: data from a Latin-American cohort. Rheumatology 2012;51:1293-8.
19. Sacre K, Criswell LA, McCune JM. Hydroxychloroquine is associated with impaired interferon-alpha and tumor necrosis factor-alpha production by plasmacytoid dendritic cells in systemic lupus erythematosus. Arthritis Res Ther 2012;14:R155.
20. Borchers AT, Naguwa SM, Shoenfeld Y et al. The geoepidemiology of systemic lupus erythematosus. Autoimmun Rev 2010;9:A277-87.
21. Gedalia A, Molina JF, Molina J et al. Childhood-onset systemic lupus erythematosus: a comparative study of African Americans and Latin Americans. J Natl Med Assoc 1999;91:497-501.
22. Gilkeson GS, James JA, Kamen DL et al. The United States to Africa lupus prevalence gradient revisited. Lupus 2011;20:1095-103.
23. Johnson AE, Gordon C, Palmer RG, Bacon PA. The prevalence and incidence of systemic lupus erythematosus in Birmingham, England. Relationship to ethnicity and country of birth. Arthritis Rheum 1995;38:551-8.
24. Seldin MF, Qi L, Scherbarth HR et al. Amerindian ancestry in Argentina is associated with increased risk for systemic lupus erythematosus. Genes Immun 2008;9:389-93.
25. Alarcón GS, McGwin G Jr, Petri M et al. The PROFILE Study. Baseline characteristics of a multiethnic lupus cohort: PROFILE. Lupus 2002;11:95-101.
26. Pomara C, Neri M, Bello S et al. C3a, TNF-a and interleukin myocardial expression in a case of fatal sudden cardiac failure during clinic reactivation of systemic lupus erythematosus. Lupus 2010;19:1246-9.
27. Hoffman IE, Peene I, Meheus L et al. Specific antinuclear antibodies are associated with clinical features in systemic lupus erythematosus. Ann Rheum Dis 2004;63:1155-8.
28. Mak A, Isenberg DA, Lau CS. Global trends, potential mechanisms and early detection of organ damage in SLE. Nat Rev Rheumatol 2013;9:301-10.
29. Zhang J, González LA, Roseman JM et al. Predictors of the rate of change in disease activity over time in LUMINA, a multiethnic US cohort of patients with systemic lupus erythematosus: LUMINA LXX. Lupus 2010;19:727-33.
30. Bourré-Tessier J, Huynh T, Clarke AE et al. Features associated with cardiac abnormalities in systemic lupus erythematosus. Lupus 2011;20:1518-25.
31. Plazak W, Gryga K, Milewski M et al. Association of heart structure and function abnormalities with laboratory findings in patients with systemic lupus erythematosus. Lupus 2011;20:936-44.
32. Lin Y, Liou YM, Chen JY, Chang KC. Sinus node dysfunction as an initial presentation of adult systemic lupus erythematosus. Lupus 2011;20:1072-5.
33. Kojuri J, Nazarinia M, Ghahartars M et al. QT dispersion in patients with systemic lupus erythematosus: the impact of disease activity. BMC Cardiovasc Disord 2012;12:1.
34. Apte M, McGwin G Jr, Vilá LM et al. Associated factors and impact of myocarditis in patients with SLE from LUMINA, a multiethnic US cohort (LV). Rheumatology 2008;47:362-7.
35. O'Neill SG, Woldman S, Bailliard F et al. Cardiac magnetic resonance imaging in patients with systemic lupus erythematosus. Ann Rheum Dis 2009;68:1478-81.
36. Croca SC, Rahman A. Imaging assessment of cardiovascular disease in systemic lupus erythematosus. Clin Dev Immunol 2012;2012:694143.
37. Mavrogeni S, Bratis K, Kolovou G. Pathophysiology of Q waves in II, III, avF in systemic lupus erythematosus. Evaluation using cardiovascular magnetic resonance imaging. Lupus 2012;21:821-9.
38. Mavrogeni S, Bratis K, Markussis V et al. The diagnostic role of cardiac magnetic resonance imaging in detecting myocardial inflammation in systemic lupus erythematosus. Differentiation from viral myocarditis. Lupus 2013;22:34-43.
39. Nussinovitch U, Freire de Carvalho J, Pereira RM, Shoenfeld Y. Glucocorticoids and the cardiovascular system: state of the art. Curr Pharm Des 2010;16:3574-85.
40. Victor S, Bassler KE, Visweswaran S. The role of complementary bipartite visual analytical representations in the analysis of SNPs: a case study in ancestral informative markers. J Am Med Inform Assoc 2012;19:e5-12.
41. Yang N, Li H, Criswell LA, Gregersen PK et al. Examination of ancestry and ethnic affiliation using highly informative diallelic DNA markers: application to diverse and admixed populations and implications for clinical epidemiology and forensic medicine. Hum Genet 2005;118:382-92.
42. Galanter JM, Fernandez-Lopez JC, Gignoux CR et al. Development of a panel of genome-wide ancestry informative markers to study admixture. PLoS Genet 2012;8:e1002554.
43. Petri M, Orbai AM, Alarcón GS et al. Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum 2012;64:2677-86.
44. Pons-Estel GJ, Wojdyla D, McGwin G Jr et al. The American College of Rheumatology and the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus in two multiethnic cohorts: a commentary. Lupus 2014;23:3-9.